美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

阿里阿德

23.99

0.0000

成交量：- -

成交額：- -

市值：46.59億

市盈率：-133.28

高：23.99

開：23.99

低：23.99

收：23.99

52周最高：23.99

52周最低：23.99

股本：1.94億

流通股本：1.70億

量比：- -

換手率：- -

股息：- -

股息率：- -

每股收益(TTM):-0.1800

淨資產收益率：--

總資產收益率：--

市淨率：-100.52

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

阿里阿德

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://www.ariad.com

郵編：

- -

電話：

- -

傳真：

- -

簡介：

ARIAD Pharmaceuticals, Inc.的前景是通過具有突破性的藥物治療癌症患者。該公司致力於發現、開發和推廣小分子藥物來治療癌症患者，滿足患者最迫切的醫療需求——目前無法治療的侵略性癌症。該公司的目標是建立一個完全集成的腫瘤學公司。該公司目前有三個正在開發中的候選產品。白血病藥物Ponatinib正處於血液腫瘤患者臨床試驗的第一階段和第二階段，包括慢性髓性白血病和費城陽性急性淋巴細胞白血病的臨床試驗。藥物AP26113正處於治療晚期實體腫瘤的臨床試驗的第一階段和第二階段。藥物Ridaforolimus正處於研究不同類型癌症患者的多個臨床試驗中。根據附註2所述的許可協議的條款，默克股份有限公司（ Merck, Sharpe & Dohme Corp. ）負責藥物Ridaforolimus相關的開發、製造和推廣活動。除了公司的主導發展計劃，該公司重點放在分子靶向癌症細胞信號通路的小分子療法的針對性藥物研發項目。該公司於1991年4月在特拉華州註冊成立。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/ARIA/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"ARIA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARIA\",,,,,undefined,":{"symbol":"ARIA","market":"US","secType":"STK","nameCN":"阿里阿德","latestPrice":23.99,"timestamp":1774036800000,"preClose":23.99,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":169700000,"shares":194200862,"eps":-0.18,"marketStatus":"已收盤","change":0,"latestTime":"03-20 16:00:00 EDT","open":23.99,"high":23.99,"low":23.99,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.18,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1774252800000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":23.99,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARIA\",,,,,undefined,":{"symbol":"ARIA","floatShares":169700000,"roa":"--","roe":"--","lyrEps":0,"shares":194200862,"dividePrice":0,"high":23.99,"amplitude":0,"preClose":23.99,"low":23.99,"week52Low":23.99,"pbRate":"-100.52","week52High":23.99,"institutionHeld":0.5771,"latestPrice":23.99,"eps":-0.18,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.18,"open":23.99,"prevYearClose":23.99,"prevWeekClose":23.99,"prevMonthClose":23.99,"prevQuarterClose":23.99,"fiveDayClose":23.99,"twentyDayClose":23.99,"sixtyDayClose":23.99},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ARIA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2016-11-07","symbol":"ARIA","fiscalQuarterEnding":null,"expectedEps":-0.19,"name":null,"time":"盤前","type":"earning","dateTimestamp":1478494800000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2016-07-28","symbol":"ARIA","fiscalQuarterEnding":null,"expectedEps":0.57,"name":null,"time":"盤前","type":"earning","dateTimestamp":1469678400000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2016-05-10","symbol":"ARIA","fiscalQuarterEnding":null,"expectedEps":-0.28,"name":null,"time":"盤前","type":"earning","dateTimestamp":1462852800000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2016-02-23","symbol":"ARIA","fiscalQuarterEnding":null,"expectedEps":-0.28,"name":null,"time":"盤前","type":"earning","dateTimestamp":1456203600000,"reportTimeType":"pre","actualEps":-0.32},{"market":"US","date":"2015-11-03","symbol":"ARIA","fiscalQuarterEnding":null,"expectedEps":-0.2,"name":null,"time":"盤前","type":"earning","dateTimestamp":1446526800000,"reportTimeType":"pre","actualEps":-0.29}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ARIA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ARIA\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.ariad.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0094},{"period":"1month","weight":-0.0338},{"period":"3month","weight":-0.0305},{"period":"6month","weight":-0.0059},{"period":"1year","weight":0.1634},{"period":"ytd","weight":-0.0324}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"ARIAD Pharmaceuticals, Inc.的前景是通過具有突破性的藥物治療癌症患者。該公司致力於發現、開發和推廣小分子藥物來治療癌症患者，滿足患者最迫切的醫療需求——目前無法治療的侵略性癌症。該公司的目標是建立一個完全集成的腫瘤學公司。該公司目前有三個正在開發中的候選產品。白血病藥物Ponatinib正處於血液腫瘤患者臨床試驗的第一階段和第二階段，包括慢性髓性白血病和費城陽性急性淋巴細胞白血病的臨床試驗。藥物AP26113正處於治療晚期實體腫瘤的臨床試驗的第一階段和第二階段。藥物Ridaforolimus正處於研究不同類型癌症患者的多個臨床試驗中。根據附註2所述的許可協議的條款，默克股份有限公司（ Merck, Sharpe & Dohme Corp. ）負責藥物Ridaforolimus相關的開發、製造和推廣活動。除了公司的主導發展計劃，該公司重點放在分子靶向癌症細胞信號通路的小分子療法的針對性藥物研發項目。該公司於1991年4月在特拉華州註冊成立。","yearOnYearQuotes":[{"month":1,"riseRate":0.517241,"avgChangeRate":0.16958},{"month":2,"riseRate":0.448276,"avgChangeRate":0.086058},{"month":3,"riseRate":0.392857,"avgChangeRate":-0.009238},{"month":4,"riseRate":0.464286,"avgChangeRate":0.03145},{"month":5,"riseRate":0.428571,"avgChangeRate":0.027992},{"month":6,"riseRate":0.285714,"avgChangeRate":-0.004208},{"month":7,"riseRate":0.321429,"avgChangeRate":-0.004919},{"month":8,"riseRate":0.464286,"avgChangeRate":0.016814},{"month":9,"riseRate":0.392857,"avgChangeRate":0.01499},{"month":10,"riseRate":0.310345,"avgChangeRate":-0.021336},{"month":11,"riseRate":0.482759,"avgChangeRate":0.074931},{"month":12,"riseRate":0.310345,"avgChangeRate":0.023298}],"exchange":"NASDAQ","name":"阿里阿德","nameEN":"ARIAD Pharmaceuticals"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"ARIA\",market:\"US\",,,undefined,":null}}